You are using an unsupported browser.
Some features of this site may not function properly. For optimal user experience, please view this site in Chrome, Firefox, Safari, or Edge.

SARS-CoV-2

Test Information
I am a:
${ profile.name.substring(0, profile.name.length - 1) }
Request Info
#carousel-content-0 .carousel-layout > .row > div[class*="col"]:nth-child(n + ${ activeRow * colCount + 1 }$), #carousel-content-0 .carousel-layout > .row > div[class*="col"]:nth-last-child(n + ${ storyCount - (activeRow - 1) * colCount + 1}$) { visibility: hidden; max-height: 0px; overflow: hidden; margin-bottom: 0; opacity: 0; left: 30px; }

Better Infection Prevention with On-Demand Molecular Diagnostics

Better and faster answers from diagnostic tests enhance treatment and infection prevention efforts. Only Cepheid delivers these fast and accurate results so you can:

  • Get easy to interpret answers to use for cost-effective patient management1
  • Improve implementation of infection prevention policies2
  • Support better clinical decisions to improve patient outcomes4
  • Reduce the number of surgical site infections by using targeted decolonization strategies5
  • Elevate antibiotic stewardship and reduce unnecessary therapy costs5
  • Minimize follow-up visits by optimizing treatment early6

Four Core Actions to Fight Infections & Antimicrobial Resistance

1

Preventing the Spread

2

Tracking Resistant Bacteria

3

Improving Antibiotic Prescribing and Stewardship

4

Developing Advanced Diagnostics & New Antibiotics

Impact of Rapid Diagnostics

Shortened hospital length of stay by 2.5 days3

Decreased lethal bloodstream infections in patients by 36%3

Reduced time to effective therapy by 5 hours3

#carousel-content-3 .carousel-layout > .row > div[class*="col"]:nth-child(n + ${ activeRow * colCount + 1 }$), #carousel-content-3 .carousel-layout > .row > div[class*="col"]:nth-last-child(n + ${ storyCount - (activeRow - 1) * colCount + 1}$) { visibility: hidden; max-height: 0px; overflow: hidden; margin-bottom: 0; opacity: 0; left: 30px; }
VIDEO

Carbapenem Resistance: A Medical and Public Health Challenge

Dr. Fred Tenover discusses the value of GeneXpert to support infection prevention in communities all over the world.

Watch Video

VIDEO

10 Hammersmith Broadway

Traditional Sexual Health services are based in hospitals. 10 Hammersmith Broadway moves sexual health services from the hospital into the heart of a neighborhood, revolutionizing the way the clinic serves the needs of its community while creating a better path forward.

Watch Video

Related White Papers

White Paper: Cepheid Presurgical Molecular Testing
DOCUMENT

White Paper: Cepheid Presurgical Molecular Testing

White Paper: Preventing "Nightmare Bacteria" from Becoming Nightmare Outbreaks
DOCUMENT

White Paper: Preventing "Nightmare Bacteria" from Becoming Nightmare Outbreaks

In early 2015, carbapenem-resistant Enterobacteriaceae (CRE) became a household term when a high-profile outbreak — including two deaths — at a California hospital were linked to contaminated medical scopes.

White Paper: Active Surveillance Testing with Targeted MRSA Decolonization
DOCUMENT

White Paper: Active Surveillance Testing with Targeted MRSA Decolonization

Related Product Links

#carousel-content-6 .carousel-layout > .row > div[class*="col"]:nth-child(n + ${ activeRow * colCount + 1 }$), #carousel-content-6 .carousel-layout > .row > div[class*="col"]:nth-last-child(n + ${ storyCount - (activeRow - 1) * colCount + 1}$) { visibility: hidden; max-height: 0px; overflow: hidden; margin-bottom: 0; opacity: 0; left: 30px; }
Xpert® Carba-R

Xpert® Carba-R is a qualitative, on-demand real-time PCR test for the detection and differentiation of KPC, NDM, VIM, OXA-48 and IMP in 48-minutes

Xpert® MRSA NxG

Accurate, Fast, On-demand PCR Test That Detects MRSA Directly from Nasal Swabs

Xpert® SA Nasal Complete

Pre-surgical testing of S. aureus and MRSA in about an hour

Xpert® MRSA/SA BC

Accurate detection of MRSA and SA in positive blood culture specimens in about an hour

Xpert® MRSA/SA SSTI

Detect MRSA & SA Skin and Soft Tissue Infections In About One Hour

Xpert® vanA

The first rapid & accurate test to assist with VRE surveillance

Xpert® C. difficile

Detection of Clostridium difficile in 40 minutes*

Xpert® Norovirus

Accurate and Easy to Use with Fast Results When Time Matters

Xpert® CT/NG

90-minute detection and differentiation of Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG)

Xpert® GBS

For direct intrapartum screening in labor/delivery

Xpert TV
Xpert® TV

The first and only FDA-cleared molecular Trichomonas vaginalis test for both women and men

Xpert® Xpress Strep A

Qualitative real-time PCR test providing accurate detection of Group A Streptococcus in as soon as 18 minutes*

Xpert® Xpress Flu/RSV

Accurate and reliable detection of Flu A, Flu B or RSV in as soon as 20 minutes*

Connect To Better Outcomes

Request Info

1.Casari E, et al. Reducing rates of Clostridium difficile infection by switching to a stand-alone NAAT with clear sampling criteria. Antimicrob Resist Infect Control. 2018;7:40.

2.Birgand G, et al. Rapid detection of glycopeptide-resistant enterococci: impact on decision-making and costs. Antimicrob Resist Infect Control. 2013 Nov 4;2(1):30.

3.Wenzler E, Using rapid diagnostics to fight resistance. Infectious Disease Special Edition. May 30, 2018. https://www.idse.net/Resistance--Stewardship/Article/09-15/Using-Rapid-
Diagnostics-to-Fight-Resistance/48730. Accessed 12 July 2018

4.Bauer KA, et al. An Antimicrobial Stewardship Program’s Impact with Rapid olymerase chain reaction methicillin-resistant/ Staphylococcus Blood Culture Test in Patients with Staphylococcus Bacteremia. ClinInfect Dis. 2010; 51(9):1074–1080.

5.Humphreys H, et al. Staphylococcus and surgical site infections: benefits of screening and decolonization before surgery. J Hosp Infect. 2016. Nov;94(3):295-304.

6.Rudd K, et al. Molecular Diagnostics Can Lead To Early Optimization of Antimicrobial Therapy for Staphylococcal Bacteremia: Experience at a Large Tertiary-Care VA Medical Center. Open Forum Infectious Diseases, Volume 3, Issue suppl_1, 1 December 2016, 1863. Accessed 12 July 2018.

Back to Top